Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins
AU - Khalek, Irene S.
AU - Laxme, R. R.Senji
AU - Nguyen, Yen Thi Kim
AU - Khochare, Suyog
AU - Patel, Rohit N.
AU - Woehl, Jordan
AU - Smith, Jessica M.
AU - Saye-Francisco, Karen
AU - Kim, Yoojin
AU - Mindrebo, Laetitia Misson
AU - Tran, Quoc
AU - Kędzior, Mateusz
AU - Boré, Evy
AU - Limbo, Oliver
AU - Verma, Megan
AU - Stanfield, Robyn L.
AU - Menzies, Stefanie K.
AU - Ainsworth, Stuart
AU - Harrison, Robert A.
AU - Burton, Dennis R.
AU - Sok, Devin
AU - Wilson, Ian A.
AU - Casewell, Nicholas R.
AU - Sunagar, Kartik
AU - Jardine, Joseph G.
N1 - Publisher Copyright: © 2024 The Authors, some rights reserved.
PY - 2024/2/21
Y1 - 2024/2/21
N2 - Snakebite envenoming is a major global public health concern for which improved therapies are urgently needed. The antigenic diversity present in snake venom toxins from various species presents a considerable challenge to the development of a universal antivenom. Here, we used a synthetic human antibody library to find and develop an antibody that neutralizes long-chain three-finger α-neurotoxins produced by numerous medically relevant snakes. our antibody bound diverse toxin variants with high affinity, blocked toxin binding to the nicotinic acetylcholine receptor in vitro, and protected mice from lethal venom challenge. structural analysis of the antibody-toxin complex revealed a binding mode that mimics the receptor-toxin interaction. The overall workflow presented is generalizable for the development of antibodies that target conserved epitopes among antigenically diverse targets, and it offers a promising framework for the creation of a monoclonal antibody–based universal antivenom to treat snakebite envenoming.
AB - Snakebite envenoming is a major global public health concern for which improved therapies are urgently needed. The antigenic diversity present in snake venom toxins from various species presents a considerable challenge to the development of a universal antivenom. Here, we used a synthetic human antibody library to find and develop an antibody that neutralizes long-chain three-finger α-neurotoxins produced by numerous medically relevant snakes. our antibody bound diverse toxin variants with high affinity, blocked toxin binding to the nicotinic acetylcholine receptor in vitro, and protected mice from lethal venom challenge. structural analysis of the antibody-toxin complex revealed a binding mode that mimics the receptor-toxin interaction. The overall workflow presented is generalizable for the development of antibodies that target conserved epitopes among antigenically diverse targets, and it offers a promising framework for the creation of a monoclonal antibody–based universal antivenom to treat snakebite envenoming.
U2 - 10.1126/scitranslmed.adk1867
DO - 10.1126/scitranslmed.adk1867
M3 - Journal article
C2 - 38381847
AN - SCOPUS:85185619790
VL - 16
JO - Science Translational Medicine
JF - Science Translational Medicine
SN - 1946-6234
IS - 735
M1 - eadk1867
ER -